January 28, 2017 | Vancouver Sun | Read this article in the Vancouver Sun to hear about the applications of our 3D bioprinting technology, our latest deal with Johnson & Johnson to develop 3D bioprinted meniscus tissue, and CEO Tamer Mohamed’s take on the British Columbia tech sector.
Aspect Media Coverage
January 28, 2017 | The Economist | This article in The Economist features our collaboration with Johnson & Johnson and discusses the growing field of bioprinting.
VANCOUVER, BC, Canada – January 5, 2017 – Aspect Biosystems Ltd., a leader in the field of 3D bioprinting and tissue engineering, announced today that it has entered into a research collaboration with DePuy Synthes Products Inc. Under the agreement, facilitated by Johnson & Johnson Innovation, Aspect’s proprietary Lab-on-a-Printer™ 3D bioprinting platform will be used […]
VANCOUVER, BC, Canada – December 14, 2016 – Aspect CEO Tamer Mohamed has been selected as a speaker for #BCTECH Summit 2017 – the largest technology conference in British Columbia. The 2nd annual conference takes place March 14-15, 2017 in Vancouver, BC and will showcase the province’s vibrant technology industry. Tamer will be speaking in the […]
VANCOUVER, BC, Canada – December 1, 2016 –Aspect Biosystems CEO Tamer Mohamed has been selected to speak at TEDxStanleyPark on March 4, 2017 at Queen Elizabeth Theatre in Vancouver, BC. TEDxStanleyPark is one of the world’s largest TED conferences. High-impact talks address a diverse range of humanity’s tough challenges and offer practical and optimistic solutions. These talks inspire, […]
VANCOUVER, BC, Canada – November 30, 2016 – Aspect Biosystems Ltd., a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering, is pleased to announce that it has been selected to join the Canadian Technology Accelerator San Francisco (CTA SF) Life Sciences program, run by the Canadian Consulate General […]